Fox Run Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Sell |
19,146
-13,524
| -41% | -$275K | 0.06% | 559 |
|
|
2025
Q1 | $593K | Buy |
32,670
+9,380
| +40% | +$170K | 0.09% | 414 |
|
|
2024
Q4 | $589K | Buy |
23,290
+13,966
| +150% | +$353K | 0.11% | 382 |
|
|
2024
Q3 | $317K | Buy |
+9,324
| New | +$317K | 0.07% | 521 |
|
|
2024
Q2 | – | Sell |
-4,824
| Closed | -$202K | – | 810 |
|
|
2024
Q1 | $202K | Sell |
4,824
-6,425
| -57% | -$270K | 0.04% | 632 |
|
|
2023
Q4 | $446K | Buy |
+11,249
| New | +$446K | 0.11% | 346 |
|